Literature DB >> 30838933

Local Delivery of Silk-Cellulose Incorporated with Stromal Cell-Derived Factor-1α Functionally Improves the Uterus Repair.

Hongxia Cai1,2,3, Bingbing Wu1,2,3, Yu Li1,2,3, Yixiao Liu2,3, Libing Shi1,2,3, Lin Gong2,3, Yaxian Xia4, Boon Chin Heng5, Huiling Wu6, Hongwei Ouyang2,3,7, Zhenghua Zhu8, Xiaohui Zou1,2,3.   

Abstract

Severe infection and mechanical injury of the uterus may lead to infertility and miscarriage. Currently, there is a lack of effective treatment modality for functional repair of uterine injury. To address this clinical challenge, this study aimed to develop a chemotactic composite scaffold by incorporating recombinant human stromal cell-derived factor-1α (rhSDF-1α) into a silk fibroin-bacterial cellulose (SF-BC) membrane carrier. A rat model of uterine injury was utilized for this study, which was composed of three groups as follows: blank control, implantation with SF-BC only, or SF-BC loaded with rhSDF-1α. The tissue regeneration efficacy of the three groups was analyzed and compared. The results showed that SF-BC loaded with rhSDF-1α significantly enhanced endometrial regeneration and arteriogenesis of the injured rat uterus, which led to improved pregnancy outcomes, thus indicating much promise for functional uterine repair and regeneration. Impact Statement In this study, we demonstrated that the silk fibroin-bacterial cellulose (SF-BC) membrane possessed good physical, chemical, and biocompatibility properties in vitro. The in vivo study showed that the incorporation of recombinant human stromal cell-derived factor-1α (rhSDF-1α) within the SF-BC membrane promoted regeneration of full-thickness uterine injury and also improved the pregnancy outcome of the damaged uterus. The results thus suggest that SF-BC loaded with rhSDF-1α has good potential in future clinical applications for the repair of uterine injury.

Entities:  

Keywords:  SDF-1α; bacterial cellulose; pregnancy; repair and regeneration; silk fibroin; uterine injury

Mesh:

Substances:

Year:  2019        PMID: 30838933     DOI: 10.1089/ten.TEA.2018.0283

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  4 in total

Review 1.  Bioengineering of the Uterus.

Authors:  Yushi Yoshimasa; Tetsuo Maruyama
Journal:  Reprod Sci       Date:  2021-04-07       Impact factor: 3.060

Review 2.  Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.

Authors:  X Li; H-F Lv; R Zhao; M-F Ying; A T Samuriwo; Y-Z Zhao
Journal:  Mater Today Bio       Date:  2021-02-25

Review 3.  Research progress of stem cell therapy for endometrial injury.

Authors:  Juan Cen; Yichen Zhang; Yindu Bai; Shenqian Ma; Chuan Zhang; Lin Jin; Shaofeng Duan; Yanan Du; Yuqi Guo
Journal:  Mater Today Bio       Date:  2022-08-08

Review 4.  Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues.

Authors:  Lin-Cui Da; Yan Sun; Yun-Hong Lin; Su-Zhu Chen; Gang-Xin Chen; Bei-Hong Zheng; Sheng-Rong Du
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.